SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sugen (SUGN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Miljenko Zuanic who wrote (314)3/26/1999 12:26:00 PM
From: gao seng  Read Replies (1) of 550
 
What is your point? SUGN's product has already been shown to be non-toxic ( the purpose of Phase I trials). Thalidomide has nothing to do with SUGN. Unless you have just crawled out from under a rock, you should already know that Thalidomide is toxic. More funding means (to me) a greater chance of success and an increase in confidence of the company. Why don't you just ask "Why is SUGN concentrating on colon cancer instead of all cancer" This is not an attack on you, but I do think you should defend your attack on sugn with some valid reasoning.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News